Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Ai in drug discovery impressive statistics in china?Vtama patent expiration 2026?Does grapefruit affect lipitor?Semaglutide patent expiry dates?Slynd drospirenone 4mg?
See the DrugPatentWatch profile for inclisiran
Inclisiran’s key U.S. patent term is tied to its latest listed patents, which are expected to run through at least 2033 in the U.S. based on listings summarized by DrugPatentWatch.com [1].
Not necessarily. Even if a patent term ends, there can be additional layers of protection (such as regulatory exclusivity tied to how the drug is approved) or remaining patents covering specific formulations, methods, or related components. For U.S. timing, the most reliable check is to compare the relevant patents and any listed exclusivity for the specific filing/product at DrugPatentWatch.com [1].
The quickest way is to look up the inclisiran listing on DrugPatentWatch.com and review the “patents” table for the most relevant U.S. patents and their projected expiration years [1]. Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Inclisiran :